First Eagle Investment Management’s Gilead Sciences GILD Stock Holding History

First Eagle Investment Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-59,700	Closed	-$4.28M	–	220
2017 Q4	$4.28M	Hold	59,700	–	–	0.01%	171
2017 Q3	$4.84M	Hold	59,700	–	–	0.01%	174
2017 Q2	$4.23M	Hold	59,700	–	–	0.01%	172
2017 Q1	$4.05M	Buy	59,700 +10,000	+20%	+$703K	0.01%	173
2016 Q4	$3.56M	Hold	49,700	–	–	0.01%	181
2016 Q3	$3.93M	Buy	49,700 +34,200	+221%	+$2.78M	0.01%	195
2016 Q2	$1.29M	Buy	15,500 +6,300	+68%	+$559K	﹤0.01%	241
2016 Q1	$845K	Buy	9,200 +8,800	+2,200%	+$794K	﹤0.01%	242
2015 Q4	$40K	Hold	400	–	–	﹤0.01%	284
2015 Q3	$39K	Hold	400	–	–	﹤0.01%	283
2015 Q2	$47K	Hold	400	–	–	﹤0.01%	275
2015 Q1	$39K	Sell	400 -1,314,688	-100%	-$133M	﹤0.01%	294
2014 Q4	$124M	Buy	1,315,088 +1,314,688	+328,672%	+$136M	0.3%	81
2014 Q3	$43K	Hold	400	–	–	﹤0.01%	296
2014 Q2	$33K	Hold	400	–	–	﹤0.01%	294
2014 Q1	$28K	Hold	400	–	–	﹤0.01%	356
2013 Q4	$30K	Hold	400	–	–	﹤0.01%	343
2013 Q3	$25K	Hold	400	–	–	﹤0.01%	328
2013 Q2	$20K	Buy	+400	New	+$20.8K	﹤0.01%	328

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

First Eagle Investment Management's GILD Position: Q1 2018 in Review

First Eagle Investment Management sold out of Gilead Sciences (GILD) in Q1 2018, closing a stake of 59,700 shares — an estimated $4.28M sold.

First Eagle Investment Management first reported a position in GILD in Q2 2013 and held it in 19 quarters. The position peaked at $124M in Q4 2014. 1,565 funds tracked by Wall St. Rank hold GILD as of Q1 2018.

First Eagle Investment Management reported no remaining Gilead Sciences position as of Q1 2018 after selling out during the quarter.
First Eagle Investment Management sold 59,700 Gilead Sciences shares in Q1 2018, an estimated $4.28M.
First Eagle Investment Management first reported a position in Gilead Sciences in Q2 2013 and held it in 19 quarters.
First Eagle Investment Management's Gilead Sciences position peaked at $124M in Q4 2014.
1,565 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2018.

Based on First Eagle Investment Management's 13F filing for Q1 2018, filed 4 May 2018.